PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 219 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 0.77 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $245,000 | -56.1% | 6,440 | -50.4% | 0.00% | -75.0% |
| Q4 2018 | $558,000 | +93.8% | 12,980 | +115.2% | 0.00% | +100.0% |
| Q3 2018 | $288,000 | +9.1% | 6,031 | +4.1% | 0.00% | 0.0% |
| Q4 2017 | $264,000 | +20.5% | 5,794 | -0.6% | 0.00% | 0.0% |
| Q3 2017 | $219,000 | -14.1% | 5,829 | +8.9% | 0.00% | 0.0% |
| Q2 2017 | $255,000 | +7.1% | 5,355 | +2.7% | 0.00% | 0.0% |
| Q1 2017 | $238,000 | – | 5,213 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |